Atai Beckley (ATAI) EBITDA Margin (2021 - 2025)
Atai Beckley's EBITDA Margin came in at -3765.42% for Q3 2025, up 52532.08 percentage points from -56297.50% a year earlier but down 281.97 percentage points from the prior quarter.
Powered by 
Analysis
Atai Beckley (ATAI) EBITDA Margin (2021 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Atai Beckley reported EBITDA Margin of -3427.53%, up 28484.25 percentage points year-over-year; for FY2024, it was -33187.66%, up 6669.66 percentage points from FY2023.
- EBITDA Margin carries a three-year change of -32521.40 percentage points (FY2021 to FY2024).
- Going back by year, EBITDA Margin was -39857.32% in FY2023 (+22210.92 pp), -62068.24% in FY2022 (-61401.98 pp) and -666.26% in FY2021.
- The five-year range for quarterly EBITDA Margin is -185888.89% (Q4 2023) to 20.40% (Q1 2021).
- Year-over-year, EBITDA Margin increased in three of the last five quarters, with an average year-over-year change of -9036.97 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q3 2023 (a gain of 129187.21 percentage points), and the weakest in Q3 2022 (a drop of 147401.47 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Atai Beckley | 1.77 Bn | 1.77 Bn | - | -3,765.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -3,765.42% |
| Jun 30, 2025 | -3,483.45% |
| Mar 31, 2025 | -1,296.08% |
| Sep 30, 2024 | -56,297.50% |
| Jun 30, 2024 | -9,394.51% |
| Dec 31, 2023 | -185,888.89% |
| Sep 30, 2023 | -30,758.62% |
| Jun 30, 2023 | -18,478.49% |
| Mar 31, 2023 | -89,591.89% |
| Dec 31, 2022 | -98,715.79% |
| Sep 30, 2022 | -159,945.83% |
| Jun 30, 2022 | -20,787.06% |
| Dec 31, 2021 | -19,628.70% |
| Sep 30, 2021 | -12,544.36% |
| Mar 31, 2021 | 20.40% |
API Access
Atai Beckley EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ATAI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ATAI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ATAI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();